33c gives a $220 million market cap. We should be over double that Just on the pending DMD approval trial when the funding is sorted and announced.
If this data shows again that the CD4, 8 and 49 bio markets are a thing, we have a true platform drug for Inflammation.
So dont sell yaself short : )
